ID   MDA-Panc-28
AC   CVCL_3917
SY   MDA Panc-28; MDAPanc-28; MDAPanc28
DR   BTO; BTO_0003303
DR   EFO; EFO_0022355
DR   cancercelllines; CVCL_3917
DR   Wikidata; Q54904650
RX   PubMed=8656025;
CC   Doubling time: ~48 hours (PubMed=8656025).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=8656025).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
RX   PubMed=8656025; DOI=10.1007/BF02788373;
RA   Frazier M.L., Fernandez E., de Llorens R., Brown N.M., Pathak S.,
RA   Cleary K.R., Abbruzzese J.L., Berry K., Olive M., Le Maistre A.,
RA   Evans D.B.;
RT   "Pancreatic adenocarcinoma cell line, MDAPanc-28, with features of
RT   both acinar and ductal cells.";
RL   Int. J. Pancreatol. 19:31-38(1996).
//